Trial intelligence / Profile preview

Remimazolam vs midazolam for sedation during dental extraction in highly dentophobic adults

ChiCTR2200066544Phase 4Not yet recruiting

Sponsor
Department of Anesthesiology, Hospital of Stomatology, Wuhan University
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Dental anxiety and procedural pain (2 arms), sponsored by Department of Anesthesiology, Hospital of Stomatology, Wuhan University. Primary endpoints: Success rate of sedation, Compliance and 3 more. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Dental anxietyprocedural pain

Beyond the preview

Go deeper on ChiCTR2200066544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call